­
Rush or Wait? The EUA Dilemma – Elexes
Elexes Medical Consulting

FDA Emergency Use Authorization (EUA) program is a great way to help out in an emergency situation, whether it is for diagnosis, monitoring patient’s vitals, or treating the patients suffering from COVID 19. One of the best ways to give back.

While an EUA is a NO BRAINER for companies with product portfolios, there are some things for a startup to consider.

The products are authorized for use under an EUA only until the emergency situation lasts and the applicability expires once the FDA terminates the emergency.
Manufacturers of EUA devices with no other FDA approval will have to dispose of their product, however, others will go back to “normal use”.
Timelines of the approvals are case dependent, “within hours or days” provided all necessary data is submitted. Important part is “all necessary data” to sufficiently demonstrate the product’s benefits and risk profile.

Here is a practical decision tree to help you decide.

“RUSH” indicates it’s time to quickly begin understanding what information is needed and pursue an EUA.

“WAIT” indicates it would be better to pursue a 510 k, PMA or DeNovo.

Leave a Reply




You may also like

Medical Devices

Clinical trials in South Africa – worldwide accepted data

Clinical trials being a resource, cost, and time extensive process, identifying the right location for a clinical trial

Medical Devices

RUO – A Market Opportunity for IVD companies

Getting an IVD product to the market is a cumbersome task and takes several months to over a year to finally get everyth

Medical Devices

Official Number is now 15 – MDD to MDR + IVDD to IVDR Planning

Everyone knows that the advent of MDR was postponed, and the new regulation shall be in full force from May 26, 2021. As

Medical Devices

Who regulates your products?

The first step towards bringing your product to the market is understanding which center at the FDA shall regulate your